Atlas Trials

Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome

Clinical trial NCT05079529 · UNKNOWN

Trial details

NCT number
NCT05079529
Sponsor
University of Brawijaya
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiometabolic Syndrome
Start date
2021-06-30
Primary completion
2021-12-28
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.